223 related articles for article (PubMed ID: 38256018)
1. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract][Full Text] [Related]
2. NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes.
Taketani T; Taki T; Nakamura H; Taniwaki M; Masuda J; Hayashi Y
Cancer Genet Cytogenet; 2009 Apr; 190(2):108-12. PubMed ID: 19380029
[TBL] [Abstract][Full Text] [Related]
3. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
[TBL] [Abstract][Full Text] [Related]
4. NSD3S stabilizes MYC through hindering its interaction with FBXW7.
Gonzalez-Pecchi V; Kwan AK; Doyle S; Ivanov AA; Du Y; Fu H
J Mol Cell Biol; 2020 Jul; 12(6):438-447. PubMed ID: 31638140
[TBL] [Abstract][Full Text] [Related]
5. The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells.
Zhou Z; Thomsen R; Kahns S; Nielsen AL
Biochem Biophys Res Commun; 2010 Jul; 398(3):565-70. PubMed ID: 20599755
[TBL] [Abstract][Full Text] [Related]
6. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
7. The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation.
Rona GB; Almeida DSG; Pinheiro AS; Eleutherio ECA
Oncotarget; 2017 Aug; 8(33):54068-54081. PubMed ID: 28903324
[TBL] [Abstract][Full Text] [Related]
8. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
[TBL] [Abstract][Full Text] [Related]
9. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
[TBL] [Abstract][Full Text] [Related]
10. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
[TBL] [Abstract][Full Text] [Related]
11. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.
Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR
Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481
[TBL] [Abstract][Full Text] [Related]
12. NSD3: Advances in cancer therapeutic potential and inhibitors research.
Xiu S; Chi X; Jia Z; Shi C; Zhang X; Li Q; Gao T; Zhang L; Liu Z
Eur J Med Chem; 2023 Aug; 256():115440. PubMed ID: 37182335
[TBL] [Abstract][Full Text] [Related]
13.
Rona GB; Almeida NP; Santos GC; Fidalgo TK; Almeida FC; Eleutherio EC; Pinheiro AS
J Cell Biochem; 2019 Apr; 120(4):5377-5385. PubMed ID: 30320908
[TBL] [Abstract][Full Text] [Related]
14. The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.
He C; Li F; Zhang J; Wu J; Shi Y
J Biol Chem; 2013 Feb; 288(7):4692-703. PubMed ID: 23269674
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
[TBL] [Abstract][Full Text] [Related]
16. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract][Full Text] [Related]
17. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
[TBL] [Abstract][Full Text] [Related]
18. Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.
Li Y; Ng HQ; Ngo A; Liu S; Tan YW; Kwek PZ; Hung AW; Joy J; Hill J; Keller TH; Kang C
Biomol NMR Assign; 2017 Oct; 11(2):225-229. PubMed ID: 28808922
[TBL] [Abstract][Full Text] [Related]
19. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of histone methyltransferase NSD3 on ISO-induced cardiac hypertrophy.
Chen K; Jian D; Zhao L; Zang X; Song W; Ma J; Jia Z; Wang X; Gao C
FEBS Lett; 2019 Sep; 593(18):2556-2565. PubMed ID: 31254363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
